Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T3HK
|
|||
Former ID |
DNC009123
|
|||
Drug Name |
1-(pyridin-4-yl)piperazine
|
|||
Synonyms |
1-(4-Pyridyl)piperazine; 1008-91-9; 1-(pyridin-4-yl)piperazine; 1-Pyridin-4-yl-piperazine; 4-Piperazinopyridine; 1-(4-pyridyl)-piperazine; 4-pyridylpiperazine; 1-pyridin-4-ylpiperazine; 1-(4-pyridyl) piperazine; PIPERAZINE, 1-(4-PYRIDINYL)-; MFCD00040745; 4-(1-piperazino)pyridine; 1-(4-pyridinyl)piperazine; CHEMBL339069; 4-(1-PIPERAZINYL)PYRIDINE; 1-[4-pyridyl]piperazine; EINECS 213-764-7; 4-pyridyl piperazine; (4-pyridyl)piperazine; PubChem22899; l-(4-pyridyl)piperazine; AC1Q4WUQ; N-(4-Pyridyl)piperazine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H13N3
|
|||
Canonical SMILES |
C1CN(CCN1)C2=CC=NC=C2
|
|||
InChI |
1S/C9H13N3/c1-3-10-4-2-9(1)12-7-5-11-6-8-12/h1-4,11H,5-8H2
|
|||
InChIKey |
OQZBAQXTXNIPRA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1008-91-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phospholipase D1 (PLD1) | Target Info | Inhibitor | [1] |
BioCyc | Phospholipases | |||
KEGG Pathway | Glycerophospholipid metabolism | |||
Ether lipid metabolism | ||||
Metabolic pathways | ||||
Ras signaling pathway | ||||
cAMP signaling pathway | ||||
Sphingolipid signaling pathway | ||||
Endocytosis | ||||
Fc gamma R-mediated phagocytosis | ||||
Glutamatergic synapse | ||||
GnRH signaling pathway | ||||
Pathways in cancer | ||||
Pancreatic cancer | ||||
Choline metabolism in cancer | ||||
Panther Pathway | Angiogenesis | |||
Ras Pathway | ||||
Pathway Interaction Database | RhoA signaling pathway | |||
Arf6 trafficking events | ||||
CDC42 signaling events | ||||
Arf6 downstream pathway | ||||
mTOR signaling pathway | ||||
ErbB1 downstream signaling | ||||
IL8- and CXCR1-mediated signaling events | ||||
Alpha-synuclein signaling | ||||
Reactome | Role of phospholipids in phagocytosis | |||
WikiPathways | EGF/EGFR Signaling Pathway | |||
TSH signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privil... Bioorg Med Chem Lett. 2009 Apr 15;19(8):2240-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.